“We are happy to have successfully treated the first patient in the FlexiSurge study”
Saturday, July 12, 2014
Medisse, A Dutch biomaterial company, successfully treated the first patient with the FlexiSurge Adhesion Barrier
Eh...talk to me in about 5 years....
EDE, The Netherlands--(BUSINESS WIRE)--Medisse BV, a leading innovator and developer of synthetic resorbable soft tissue implants, today announced the successful treatment of the first patient in a clinical trial for its first innovation, FlexiSurge® Adhesion Barrier, which is designed to reduce adhesions formed after open colorectal surgery procedures. The study, currently underway in the Netherlands, marks a significant milestone in the development of the Company’s first product to revolutionize patient care.
The study, being conducted in three hospitals in the Netherlands, will http://www.businesswire.com/news/home/20140708005121/en/Medisse-Dutch-biomaterial-company-successfully-treated-patient#.U8G-yvldWHginvestigate the safety of